The Council for Responsible Nutrition (CRN) has announced that Tara Martin, general counsel, Nutrawise/You Theory, will serve as the association’s new board of directors chair beginning in January 2023. Martin succeeds Barry Ritz, PhD, chief scientific officer and vice president, professional R&D and regulatory affairs, Nestlé Health Science, who has served in the role for the past two years and will continue to serve on the board as its Immediate Past Chair. Martin will serve as chair for the next two years.
“We are pleased to announce Tara Martin’s tenure as CRN board of directors chair in 2023,” said CRN President and CEO Steve Mister. “As a board member, she has been essential in steering CRN decision making on critical issues affecting the dietary supplement and functional food industry. I look forward to working closely with her during the next two years. I also thank Barry for his leadership, particularly around the #Act4Access initiative, which raised awareness of how CRN members are actively working toward access to nutrition and nutrition education for all and helped mobilize more members in the fight against hunger.”
Joining Martin as elected officers of the Board are:
- Bruce Brown, vice president and general manager, nutrition and supplements, Kerry (Chair Elect)
- Mandy Kraynik, vice president, innovation, Nature’s Way (Treasurer)
- Mark Walsh, CEO, MeriCal (Secretary)
- Barry Ritz, PhD, Nestlé Health Science (Immediate Past Chair)
- Harvey Kamil, Piping Rock (Chair Emeritus)
In addition to the appointment of officers, the following individuals will serve as members of CRN’s Executive Committee for 2023-24: Aaron Bartz, Ortho Molecular; Aaron Bennett, Vytalogy; Christine Burdick-Bell, Pharmavite; Eric Choban, DSM; Mike Finamore, Gemini Pharmaceutical; Jennifer Holahan, Haleon; Lisa Pankiewicz, Clorox; Michelle Stout, Amway; Karen Todd, Kyowa Hakko; and Mike Yatcilla, PhD, Herbalife Nutrition.
CRN’s membership elected five new members of the Board of Directors. Joining the Board as representatives of the Finished Product Marketers/Manufacturers segment are Doug Brown, vice president, Americas, Sirio Nutrition Co. Ltd.; and Andrew Shao, PhD, senior vice president, global scientific and regulatory affairs, Chromadex. Elected from the Ingredients Suppliers segment are Justin Green, PhD, director of scientific affairs at Embria Health Sciences (re-elected); John Helfrick, director of human nutrition, BASF Corp. (re-elected); and Deshanie Rai, PhD, vice president, global scientific and regulatory affairs, OmniActive Health Technologies. All were elected to three-year terms.
“We are looking forward to the contributions of Doug, Andrew, Justin, John and Deshanie on the Board,” Mister offered. “CRN has an ambitious program of work as we continue to advance a more favorable climate for our members to develop, source, manufacture and market science-backed products for better health and nutrition. Our Board plays a critical role in developing and guiding that agenda.”
For more information, visit www.crnusa.org.